LATE DEVELOPER

LATE DEVELOPER was reported 8 times

LATE DEVELOPER is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
1 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 6 0.0001
2 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 2 0.0000